Immediate Impact
2 from Science/Nature 49 standout
Citing Papers
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
Works of Helena Ågerstam being referenced
CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting
2017
IL1RAP antibodies block IL-1–induced expansion of candidate CML stem cells and mediate cell killing in xenograft models
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Helena Ågerstam | 349 | 151 | 150 | 187 | 177 | 18 | 553 | |
| Nils Hansen | 328 | 181 | 145 | 206 | 179 | 24 | 559 | |
| Yingzhe Yu | 192 | 114 | 186 | 212 | 191 | 21 | 611 | |
| Siamak Jabbarzadeh‐Tabrizi | 240 | 98 | 169 | 247 | 308 | 13 | 635 | |
| Dominik Spensberger | 243 | 183 | 108 | 119 | 361 | 14 | 578 | |
| Koorosh Korfi | 237 | 148 | 142 | 69 | 219 | 17 | 526 | |
| Richard Smykla | 223 | 164 | 279 | 68 | 201 | 16 | 633 | |
| Hardik Modi | 343 | 218 | 81 | 84 | 220 | 17 | 577 | |
| Zineb Hamilou | 400 | 231 | 72 | 95 | 263 | 18 | 634 | |
| Brooke Snetsinger | 229 | 136 | 102 | 170 | 279 | 18 | 635 | |
| J. W. G. Janssen | 269 | 126 | 68 | 111 | 233 | 18 | 549 |
All Works
Login with ORCID to disown or claim papers
Loading papers...